The natural history of homocysteine due to cystathionine(synthase deficiency
Mudd SH Skovby F Levy HL Pettigrew KD Wilcken B Pyeritz RE The natural history of homocysteine due to cystathionine(synthase deficiency Am J Hum Genet 37 1985 1 31
A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes
Boushey CJ Shirley A Beresford A Omenn GS Motulsky AG A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes JAMA 274 1995 1049 1057
Plasma homocysteine concentrations in a population with a low coronary heart disease preva-lence
Ubbink JB Delport R Vermaak WJH Plasma homocysteine concentrations in a population with a low coronary heart disease preva-lence J Nutr 126 1996 1254 1257
The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitalin use and methylenetetrahydrofolate reductase genotypes
Malinow MR Nieto FJ Kruger WD Duell PB Hess DL Gluckman RA The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitalin use and methylenetetrahydrofolate reductase genotypes Arterioscler Thromb Vasc Biol 17 1997 1157 1162
A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase
Frosst P Blom HJ Milos R Goyette P Sheppart CA Matthews RG A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase Nature Genet 101 1995 111 113
Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocys-teinemia but not to vascular disease. The result of a meta-analysis
Brattström L Wilcken DEL Öhrvik J Brudin L Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocys-teinemia but not to vascular disease. The result of a meta-analysis Circulation 98 1998 2520 2526